diphenyleneiodonium and Cardiomyopathies, Primary

diphenyleneiodonium has been researched along with Cardiomyopathies, Primary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Champlain, J; Deschepper, CF; Girouard, H; Sadekova, N; Wu, R; Yin, D	1

Other Studies

1 other study(ies) available for diphenyleneiodonium and Cardiomyopathies, Primary

Article	Year
Protective effects of aspirin from cardiac hypertrophy and oxidative stress in cardiomyopathic hamsters. Oxidative medicine and cellular longevity, 2012, Volume: 2012 Topics: Animals; Aorta; Aspirin; Blood Pressure; Body Weight; Cardiomegaly; Cardiomyopathies; Cardiotonic Agents; Cricetinae; Fibrosis; Heart Rate; Heart Ventricles; Male; Myocardium; NADPH Oxidases; Onium Compounds; Organ Size; Oxidative Stress; Superoxides; Time Factors	2012

Article

Year

Protective effects of aspirin from cardiac hypertrophy and oxidative stress in cardiomyopathic hamsters.

Oxidative medicine and cellular longevity, 2012, Volume: 2012

Topics: Animals; Aorta; Aspirin; Blood Pressure; Body Weight; Cardiomegaly; Cardiomyopathies; Cardiotonic Agents; Cricetinae; Fibrosis; Heart Rate; Heart Ventricles; Male; Myocardium; NADPH Oxidases; Onium Compounds; Organ Size; Oxidative Stress; Superoxides; Time Factors

2012